目的:系统评价布拉氏酵母菌散治疗儿童抗生素相关性腹泻(AAD)的疗效,以为临床提供循证参考。方法:计算机检索 Cochrane 图书馆、PubMed、EMBase、Cochrane 对照试验中心数据库、中国生物医学文献数据库、中国期刊全文数据库、中文科技期 刊数据库、万方数据库,收集布拉氏酵母菌散(试验组)对比常规治疗(对照组)治疗儿童AAD的随机对照试验(RCT),对符合纳入 标准的研究提取资料并进行质量评价后,采用Rev Man 5.0 统计软件进行Meta 分析。结果:共纳入6 项研究,合计746 例患者。 Meta 分析结果显示,试验组患者有效率[RR=1.21,95%CI(1.08,1.35),P=0.001]、治愈率[RR=1.81,95%CI(1.48,2.20),P< 0.001]、腹泻持续时间[MD=-1.95,95%CI(-2.56,-1.34),P<0.001]显著优于对照组,差异均有统计学意义。结论:布拉氏酵母 菌散能有效治疗儿童AAD。
Abstract
OBJECTIVE:To systematically review the efficacy of Saccharomyces boulardii powder in the treatment of antibiotic associated diarrhea(AAD)in children,and provide evidence-based reference for clinical medication. METHODS:Retrieved from Cochrane Library,PubMed,EMBase,Cochrane Controlled Trails Database,CBM,CJFD,VIP and Wanfang database,randomized controlled trials(RCT)about Saccharomyces boulardii powder(test group)versus conventional treatment(control group)in the treatment of AAD in children were collected. Meta-analysis was performed by using Rev Man 5.0 software after quality assessment and data extract. RESULTS:A total of 6 RCTs were included,involving 746 patients. Results of Meta-analysis showed effective rate [RR=1.21,95%CI(1.08,1.35),P<0.001],cure rate [RR=1.81,95%CI(1.48,2.20),P<0.001] and duration of diarrhea [MD=-1.95,95%CI(-2.56,-1.34),P<0.001] in test group were significantly better than control group,the difference was statistically significant. CONCLUSIONS:Saccharomyces boulardii powder can effectively treat the AAD in children.